Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Objective Evaluation of Proliferative Diabetic Retinopathy Using OCT.

Schwartz R, Khalid H, Sivaprasad S, Nicholson L, Anikina E, Sullivan P, Patel PJ, Balaskas K, Keane PA.

Ophthalmol Retina. 2019 Sep 11. pii: S2468-6530(19)30554-8. doi: 10.1016/j.oret.2019.09.004. [Epub ahead of print]

PMID:
31708488
2.

Moorfields AMD database report 2: fellow eye involvement with neovascular age-related macular degeneration.

Fasler K, Fu DJ, Moraes G, Wagner S, Gokhale E, Kortuem K, Chopra R, Faes L, Preston G, Pontikos N, Patel PJ, Tufail A, Lee AY, Balaskas K, Keane PA.

Br J Ophthalmol. 2019 Oct 14. pii: bjophthalmol-2019-314446. doi: 10.1136/bjophthalmol-2019-314446. [Epub ahead of print]

PMID:
31611234
3.

Treatment decisions of UK hospital optometrists and ophthalmologists in patients with nAMD: a vignette study.

Creer RC, Roberts SA, Aslam TM, Balaskas K, Chhabra R, Mahmood S, Turner GS, Harper RA.

Ophthalmic Physiol Opt. 2019 Nov;39(6):432-440. doi: 10.1111/opo.12644. Epub 2019 Oct 10.

PMID:
31602674
4.

Validation of automated artificial intelligence segmentation of optical coherence tomography images.

Maloca PM, Lee AY, de Carvalho ER, Okada M, Fasler K, Leung I, Hörmann B, Kaiser P, Suter S, Hasler PW, Zarranz-Ventura J, Egan C, Heeren TFC, Balaskas K, Tufail A, Scholl HPN.

PLoS One. 2019 Aug 16;14(8):e0220063. doi: 10.1371/journal.pone.0220063. eCollection 2019.

5.

Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study.

Gale RP, Pearce I, Eter N, Ghanchi F, Holz FG, Schmitz-Valckenberg S, Balaskas K, Burton BJL, Downes SM, Eleftheriadis H, George S, Gilmour D, Hamilton R, Lotery AJ, Patel N, Prakash P, Santiago C, Thomas S, Varma D, Walters G, Williams M, Wolf A, Zakri RH, Igwe F, Ayan F.

Br J Ophthalmol. 2019 Aug 5. pii: bjophthalmol-2019-314251. doi: 10.1136/bjophthalmol-2019-314251. [Epub ahead of print]

6.

Implementation of a cloud-based referral platform in ophthalmology: making telemedicine services a reality in eye care.

Kern C, Fu DJ, Kortuem K, Huemer J, Barker D, Davis A, Balaskas K, Keane PA, McKinnon T, Sim DA.

Br J Ophthalmol. 2019 Jul 18. pii: bjophthalmol-2019-314161. doi: 10.1136/bjophthalmol-2019-314161. [Epub ahead of print]

7.

Comparing diabetic retinopathy lesions in scanning laser ophthalmoscopy and colour fundus photography.

Nghiem AZ, Nderitu P, Lukic M, Khatun M, Largan R, Kortuem K, Balaskas K, Sim D.

Acta Ophthalmol. 2019 Jul 8. doi: 10.1111/aos.14106. [Epub ahead of print]

PMID:
31286663
8.

One- and two-year visual outcomes from the Moorfields age-related macular degeneration database: a retrospective cohort study and an open science resource.

Fasler K, Moraes G, Wagner S, Kortuem KU, Chopra R, Faes L, Preston G, Pontikos N, Fu DJ, Patel P, Tufail A, Lee AY, Balaskas K, Keane PA.

BMJ Open. 2019 Jun 21;9(6):e027441. doi: 10.1136/bmjopen-2018-027441.

9.

Effect of total anti-VEGF treatment exposure on patterns of choroidal neovascularisation assessed by optical coherence tomography angiography in age-related macular degeneration: a retrospective case series.

Faes L, Ali Z, Wagner S, Patel PJ, Fu DJ, Bachmann LM, Schmid MK, Waheed N, Keane PA, Balaskas K.

BMJ Open Ophthalmol. 2019 Apr 9;4(1):e000244. doi: 10.1136/bmjophth-2018-000244. eCollection 2019.

10.

Clinical Outcomes of a Hospital-Based Teleophthalmology Service: What Happens to Patients in a Virtual Clinic?

Kern C, Kortuem K, Hamilton R, Fasolo S, Cai Y, Balaskas K, Keane P, Sim D.

Ophthalmol Retina. 2019 May;3(5):422-428. doi: 10.1016/j.oret.2019.01.011. Epub 2019 Jan 21.

PMID:
31044734
11.

Psychological and Psychosocial Interventions for Depression and Anxiety in Patients With Age-Related Macular Degeneration: A Systematic Review.

Senra H, Macedo AF, Nunes N, Balaskas K, Aslam T, Costa E.

Am J Geriatr Psychiatry. 2019 Aug;27(8):755-773. doi: 10.1016/j.jagp.2019.03.001. Epub 2019 Mar 7. Review.

PMID:
31005495
12.

Impact of optical coherence tomography on diagnostic decision-making by UK community optometrists: a clinical vignette study.

Jindal A, Ctori I, Fidalgo B, Dabasia P, Balaskas K, Lawrenson JG.

Ophthalmic Physiol Opt. 2019 May;39(3):205-215. doi: 10.1111/opo.12613.

PMID:
30994199
13.

Test performance of optical coherence tomography angiography in detecting retinal diseases: a systematic review and meta-analysis.

Faes L, Bodmer NS, Locher S, Keane PA, Balaskas K, Bachmann LM, Schlingemann RO, Schmid MK.

Eye (Lond). 2019 Aug;33(8):1327-1338. doi: 10.1038/s41433-019-0421-3. Epub 2019 Apr 10.

PMID:
30971815
14.

Initiation and maintenance of a Treat-and-Extend regimen for ranibizumab therapy in wet age-related macular degeneration: recommendations from the UK Retinal Outcomes Group.

Amoaku W, Balaskas K, Cudrnak T, Downey L, Groppe M, Mahmood S, Mehta H, Mohamed Q, Mushtaq B, Severn P, Vardarinos A, Yang Y, Younis S.

Clin Ophthalmol. 2018 Sep 10;12:1731-1740. doi: 10.2147/OPTH.S174560. eCollection 2018.

15.

Interdevice variability of central corneal thickness measurement.

Maloca PM, Studer HP, Ambrósio R Jr, Goldblum D, Rothenbuehler S, Barthelmes D, Zweifel S, Scholl HPN, Balaskas K, Tufail A, Hasler PW.

PLoS One. 2018 Sep 13;13(9):e0203884. doi: 10.1371/journal.pone.0203884. eCollection 2018.

16.

Swept-source optical coherence tomography angiography features of sub-retinal fibrosis in neovascular age-related macular degeneration.

Balaskas K, Ali ZC, Saddik T, Gemenetzi M, Patel P, Aslam TM.

Clin Exp Ophthalmol. 2019 Mar;47(2):233-239. doi: 10.1111/ceo.13367. Epub 2018 Nov 13.

PMID:
30066485
17.

Safety and Feasibility of a Novel Sparse Optical Coherence Tomography Device for Patient-Delivered Retina Home Monitoring.

Maloca P, Hasler PW, Barthelmes D, Arnold P, Matthias M, Scholl HPN, Gerding H, Garweg J, Heeren T, Balaskas K, de Carvalho JER, Egan C, Tufail A, Zweifel SA.

Transl Vis Sci Technol. 2018 Jul 24;7(4):8. doi: 10.1167/tvst.7.4.8. eCollection 2018 Jul.

18.

High-Performance Virtual Reality Volume Rendering of Original Optical Coherence Tomography Point-Cloud Data Enhanced With Real-Time Ray Casting.

Maloca PM, de Carvalho JER, Heeren T, Hasler PW, Mushtaq F, Mon-Williams M, Scholl HPN, Balaskas K, Egan C, Tufail A, Witthauer L, Cattin PC.

Transl Vis Sci Technol. 2018 Jul 9;7(4):2. doi: 10.1167/tvst.7.4.2. eCollection 2018 Jul.

19.

Features of choroidal naevi on swept source optical coherence tomography angiography and structural reverse flow optical coherence tomography.

Ali ZC, Gray J, Balaskas K.

Graefes Arch Clin Exp Ophthalmol. 2018 Jul;256(7):1319-1323. doi: 10.1007/s00417-018-3924-x. Epub 2018 Mar 9.

PMID:
29520479
20.

Reply.

Aslam TM, Mahmood S, Ali ZC, Ahmad NA, Thorell MR, Balaskas K.

Am J Ophthalmol. 2018 Mar;187:167-168. doi: 10.1016/j.ajo.2017.12.003. Epub 2018 Jan 12. No abstract available.

PMID:
29338850
21.

Implementation of medical retina virtual clinics in a tertiary eye care referral centre.

Kortuem K, Fasler K, Charnley A, Khambati H, Fasolo S, Katz M, Balaskas K, Rajendram R, Hamilton R, Keane PA, Sim DA.

Br J Ophthalmol. 2018 Oct;102(10):1391-1395. doi: 10.1136/bjophthalmol-2017-311494. Epub 2018 Jan 6.

PMID:
29306863
22.

Swept-Source Optical Coherence Tomography Angiography Findings in Torpedo Maculopathy.

Ali Z, Shields CL, Jasani K, Aslam TM, Balaskas K.

Ophthalmic Surg Lasers Imaging Retina. 2017 Nov 1;48(11):932-935. doi: 10.3928/23258160-20171030-10.

PMID:
29121364
23.

Use of a Neural Net to Model the Impact of Optical Coherence Tomography Abnormalities on Vision in Age-related Macular Degeneration.

Aslam TM, Zaki HR, Mahmood S, Ali ZC, Ahmad NA, Thorell MR, Balaskas K.

Am J Ophthalmol. 2018 Jan;185:94-100. doi: 10.1016/j.ajo.2017.10.015. Epub 2017 Oct 31.

PMID:
29101008
24.

Experience of Anti-VEGF Treatment and Clinical Levels of Depression and Anxiety in Patients With Wet Age-Related Macular Degeneration.

Senra H, Balaskas K, Mahmoodi N, Aslam T.

Am J Ophthalmol. 2017 May;177:213-224. doi: 10.1016/j.ajo.2017.03.005. Epub 2017 Mar 14.

PMID:
28302534
25.

QUANTITATIVE ANALYSIS OF PIGMENT EPITHELIAL DETACHMENT RESPONSE TO DIFFERENT ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS IN WET AGE-RELATED MACULAR DEGENERATION.

Balaskas K, Karampelas M, Horani M, Hotu O, Keane P, Aslam T.

Retina. 2017 Jul;37(7):1297-1304. doi: 10.1097/IAE.0000000000001342.

PMID:
27755376
26.

Psychological impact of anti-VEGF treatments for wet macular degeneration-a review.

Senra H, Ali Z, Balaskas K, Aslam T.

Graefes Arch Clin Exp Ophthalmol. 2016 Oct;254(10):1873-1880. Epub 2016 Jun 4. Review.

27.

A cross-sectional study of submacular thickening in intermediate uveitis and determination of treatment threshold.

Simonazzi B, Balaskas K, Guex-Crosier Y.

BMC Ophthalmol. 2016 May 18;16(1):59. doi: 10.1186/s12886-016-0230-4.

28.

Diagnostic and Therapeutic Challenges.

Pastor-Idoate S, Heimann H, Keane PA, Balaskas K, Lujan BJ.

Retina. 2016 Sep;36(9):1796-801. doi: 10.1097/IAE.0000000000000979. No abstract available.

PMID:
27043000
29.

Patient perceptions and experiences of stereotactic radiotherapy for wet age-related macular degeneration.

Senra H, Joseph S, Balaskas K, Horani M, Aslam T.

Eur J Ophthalmol. 2016 Jun 10;26(4):e80-2. doi: 10.5301/ejo.5000739.

PMID:
26833232
30.

The Novel Evidenced Assessment of Tortuosity system: interobserver reliability and agreement with clinical assessment.

Balaskas K, Tiew S, Czanner G, Tan AL, Ashworth J, Biswas S, Aslam T.

Acta Ophthalmol. 2016 Sep;94(6):e421-6. doi: 10.1111/aos.12907. Epub 2015 Dec 21.

31.

Automated Analysis of Vitreous Inflammation Using Spectral-Domain Optical Coherence Tomography.

Keane PA, Balaskas K, Sim DA, Aman K, Denniston AK, Aslam T, And For The Equator Study Group.

Transl Vis Sci Technol. 2015 Sep 16;4(5):4. eCollection 2015 Sep.

32.

Management of choroidal naevomelanocytic lesions: feasibility and safety of a virtual clinic model.

Balaskas K, Gray J, Blows P, Rajai A, Flaye D, Peto T, Sagoo MS.

Br J Ophthalmol. 2016 May;100(5):665-70. doi: 10.1136/bjophthalmol-2015-307168. Epub 2015 Sep 7.

PMID:
26347525
33.

Proton pump inhibitors and histamine 2 blockers are associated with improved overall survival in patients with head and neck squamous carcinoma.

Papagerakis S, Bellile E, Peterson LA, Pliakas M, Balaskas K, Selman S, Hanauer D, Taylor JM, Duffy S, Wolf G.

Cancer Prev Res (Phila). 2014 Dec;7(12):1258-69. doi: 10.1158/1940-6207.CAPR-14-0002.

34.

Associations between autofluorescence abnormalities and visual acuity in idiopathic macular telangiectasia type 2: MacTel project report number 5.

Balaskas K, Leung I, Sallo FB, Clemons TE, Bird AC, Peto T.

Retina. 2014 Aug;34(8):1630-6. doi: 10.1097/IAE.0000000000000110.

PMID:
24743635
35.

Comparison of mathematical morphological descriptors of hyporeflective cavities in optical coherence tomography of patients with macular telangiectasia compared to patients with diabetic maculopathy.

Aslam T, Tan SZ, D'Souza Y, Balaskas K, Mahmood S.

Acta Ophthalmol. 2014 Nov;92(7):e580-1. doi: 10.1111/aos.12390. Epub 2014 Mar 25. No abstract available.

36.

Repeatability of visual function measures in age-related macular degeneration.

Aslam T, Mahmood S, Balaskas K, Patton N, Tanawade RG, Tan SZ, Roberts SA, Parkes J, Bishop PN.

Graefes Arch Clin Exp Ophthalmol. 2014 Feb;252(2):201-6. doi: 10.1007/s00417-013-2421-5. Epub 2013 Jul 25.

PMID:
23884391
37.

Is indocyanine green angiography useful for the diagnosis of macular telangiectasia type 2?

Niskopoulou M, Balaskas K, Leung I, Sallo FB, Clemons TE, Bird AC, Peto T; MacTel Study group.

Br J Ophthalmol. 2013 Jul;97(7):946-8. doi: 10.1136/bjophthalmol-2013-303118. Epub 2013 Mar 26. No abstract available.

PMID:
23532616
38.

Experimental uveitis can be maintained in rabbits for a period of six weeks after a safe sensitization method.

Eperon S, Balaskas K, Vaudaux J, Guex-Crosier Y.

Curr Eye Res. 2013 Mar;38(3):405-12. doi: 10.3109/02713683.2012.747616. Epub 2013 Jan 7.

PMID:
23294112
39.

A new drug delivery system inhibits uveitis in an animal model after cataract surgery.

Eperon S, Rodriguez-Aller M, Balaskas K, Gurny R, Guex-Crosier Y.

Int J Pharm. 2013 Feb 25;443(1-2):254-61. doi: 10.1016/j.ijpharm.2012.12.033. Epub 2013 Jan 3.

PMID:
23291445
40.

Differences in spectral absorption properties between active neovascular macular degeneration and mild age related maculopathy.

Balaskas K, Nourrit V, Dinsdale M, Henson DB, Aslam T.

Br J Ophthalmol. 2013 May;97(5):558-60. doi: 10.1136/bjophthalmol-2012-302305. Epub 2012 Nov 8.

PMID:
23137662
41.

Ranibizumab for the management of Sorsby fundus dystrophy.

Balaskas K, Hovan M, Mahmood S, Bishop P.

Eye (Lond). 2013 Jan;27(1):101-2. doi: 10.1038/eye.2012.221. Epub 2012 Oct 26. No abstract available.

42.

Long-term ranibizumab treatment for choroidal neovascularization secondary to serpiginous choroiditis.

Balaskas K, Ur Rehman S, D'Souza Y.

Can J Ophthalmol. 2012 Oct;47(5):e15-7. doi: 10.1016/j.jcjo.2012.03.032. Epub 2012 Jul 6. No abstract available.

PMID:
23036551
43.

Peripapillary choroidal neovascularisation in the context of ocular syphilis is sensitive to combination antibiotic and corticosteroid treatment.

Balaskas K, Spencer S, D'Souza Y.

Int Ophthalmol. 2013 Apr;33(2):159-62. doi: 10.1007/s10792-012-9641-2. Epub 2012 Sep 27.

PMID:
23015023
44.

Infliximab therapy for a severe case of IgG4-related ocular adnexal disorder recalcitrant to corticosteroid treatment.

Balaskas K, de Leval L, La Corte R, Zografos L, Guex-Crosier Y.

Ocul Immunol Inflamm. 2012 Dec;20(6):478-80. doi: 10.3109/09273948.2012.714045. Epub 2012 Sep 4. No abstract available.

PMID:
22946470
45.

Retinal thickening in HLA-B27-associated acute anterior uveitis: evolution with time and association with severity of inflammatory activity.

Balaskas K, Ballabeni P, Guex-Crosier Y.

Invest Ophthalmol Vis Sci. 2012 Sep 14;53(10):6171-7. doi: 10.1167/iovs.12-10026.

46.

Azithromycin versus Sulfadiazine and Pyrimethamine for non-vision-threatening toxoplasmic retinochoroiditis: a pilot study.

Balaskas K, Vaudaux J, Boillat-Blanco N, Guex-Crosier Y.

Med Sci Monit. 2012 May;18(5):CR296-302.

47.

[Peripheral occlusive retinal vasculopathy in a woman with combined preeclampsia and alpha thalassemia minor].

Guber I, Balaskas K, Guex-Crosier Y.

Klin Monbl Augenheilkd. 2012 Apr;229(4):439-40. doi: 10.1055/s-0031-1299182. Epub 2012 Apr 11. German. No abstract available.

PMID:
22496025
48.

Ocular involvement in idiopathic hypereosinophilic syndrome: a rare finding.

Balaskas K, Wyss P, Guex-Crosier Y.

Klin Monbl Augenheilkd. 2012 Apr;229(4):437-8. doi: 10.1055/s-0031-1299176. Epub 2012 Apr 11. No abstract available.

PMID:
22496024
49.

Recurrent paroxysmal fever revealing ocular syphilis.

Balaskas K, Mokrim R, Guex-Crosier Y.

Klin Monbl Augenheilkd. 2012 Apr;229(4):435-6. doi: 10.1055/s-0031-1299183. Epub 2012 Apr 11. No abstract available.

PMID:
22496023
50.

Indocyanine-green angiography findings in Susac's syndrome.

Balaskas K, Guex-Crosier Y, Borruat FX.

Klin Monbl Augenheilkd. 2012 Apr;229(4):426-7. doi: 10.1055/s-0031-1299166. Epub 2012 Apr 11. No abstract available.

PMID:
22496019

Supplemental Content

Loading ...
Support Center